10 things I hate about proteomics
Abstract
Despite the title, says Dr. Williams, “this presentation is about my romance with proteomics.” From myths about assay size (and why it’s annoying when people say, “3,000 proteins is enough”) to the issue surrounding cis pQTLs (and why they’re “a nice party trick, but mostly biologically boring”), Dr. Williams explains in a fun – but serious – way how proteomics is revolutionizing drug discovery research and precision medicine worldwide today. He also couldn’t resist telling the story about what happens when two proteins walk into a bar. (Spoiler alert: This is why he has a career in medicine and not in stand-up comedy.)
Stephen A. Williams, MD, PhD
Chief Medical Officer
SomaLogic, Inc.
Stephen Williams, MD, PhD, is Chief Medical Officer at SomaLogic and is responsible for Clinical R&D, Medical Affairs, and Regulatory and Quality. He oversees clinical application of the SomaScan® Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.
Read more about Dr. Williams here.
10 things I hate about proteomics
A presentation by Stephen Williams, MD, PhD
More webinars
WebinarIdentifying Biomarkers for IBD Diagnosis and Management
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
WebinarBoutique Webinar : Predicting Pregnancy Complications with High-Plex Proteomics
The interdisciplinary team, comprising 10-15 scientists and clinician-scientists, is dedicated to advancing diagnostics and therapeutics aimed at enhancing maternal and fetal care. Their primary focus lies in the development of interventions for conditions such as ectopic pregnancy and preeclampsia, alongside the creation of diagnostics to prevent stillbirth.
WebinarYoung blood for old brains and the quest to slow brain aging
Aging leads to the degradation of function in nearly all tissues and organs. This process is marked by significant shifts in gene expression and changes in concentrations of all types of biological molecules. Recent technological progress has allowed biologists to measure an unprecedented number of these molecules throughout an organism